Best Remedy Meds Alternatives for Semaglutide and Tirzepatide in 2026

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Remedy Meds offers compounded semaglutide and tirzepatide programs with unlimited clinician visits, phone support, and a results warranty. The clearest like-for-like comparison available is microdose plans: Remedy charges $189/month (captured September 4, 2026, shown after completing intake quiz), while PlexusDx publishes microdose pricing at $129/month with no intake required—a $720 difference over 12 months. Remedy advertises standard semaglutide at approximately $299/month and tirzepatide at $399/month (evidence flagged as mixed/secondary), but requires completing a full intake questionnaire before displaying any pricing. PlexusDx publishes all prices upfront on product pages and offers injectable semaglutide at $189/month and tirzepatide at $289/month, both month-to-month. Remedy wins on bundled support; PlexusDx wins on microdose pricing and transparency. Readers interested in standard-dose programs should confirm Remedy's pricing at checkout given limited public documentation.

At-a-glance comparison: Remedy Meds vs PlexusDx

All Remedy Meds figures captured September 4, 2026. Standard semaglutide and tirzepatide prices flagged as mixed/secondary evidence; readers should confirm at checkout. PlexusDx prepaid figures are per-month equivalents requiring upfront commitment (our calculation).

Normalized 12-month cost comparison

Microdose plans (month-to-month, verified evidence)

The only direct like-for-like comparison supported by verified checkout evidence is microdose GLP-1 plans:

• PlexusDx microdose: $129/month × 12 = $1,548 annually
• Remedy Meds microdose: $189/month × 12 = $2,268 annually
• 12-month difference: $720 (PlexusDx costs $720 less over one year)

Both figures are all-inclusive: medication, clinician consultation, and shipping. Remedy's microdose price was captured from intake completion (September 4, 2026); PlexusDx microdose is published on the product page. Remedy includes unlimited follow-up visits and phone support in the base price; PlexusDx includes the initial consultation and prescription but does not advertise unlimited ongoing visits as part of the microdose program.

Standard semaglutide injection (month-to-month, mixed evidence)

Remedy Meds advertises compounded semaglutide at approximately $299/month (evidence flagged as mixed/secondary, from a Forbes review and partial intake capture, September 4, 2026). PlexusDx publishes semaglutide injection at $189/month:

• PlexusDx semaglutide: $189/month × 12 = $2,268 annually
• Remedy Meds semaglutide: $299/month × 12 = $3,588 annually (if accurate)
• 12-month difference: $1,320 (PlexusDx costs $1,320 less over one year, pending confirmation of Remedy's published rate)

Readers interested in standard semaglutide should complete Remedy's intake to confirm the $299 figure at checkout. PlexusDx pricing is published and does not change by dose.

Standard tirzepatide injection (month-to-month, mixed evidence)

Remedy Meds advertises compounded tirzepatide at approximately $399/month (evidence flagged as mixed/secondary, from a Forbes review, September 4, 2026). PlexusDx publishes tirzepatide injection at $289/month:

• PlexusDx tirzepatide: $289/month × 12 = $3,468 annually
• Remedy Meds tirzepatide: $399/month × 12 = $4,788 annually (if accurate)
• 12-month difference: $1,320 (PlexusDx costs $1,320 less over one year, pending confirmation of Remedy's published rate)

Again, readers should confirm Remedy's tirzepatide pricing at checkout, as the $399 figure is secondary evidence from a third-party review rather than direct capture from the Remedy checkout flow.

Decision factors: where Remedy Meds and PlexusDx differ

Price transparency

PlexusDx publishes all program prices on product pages before intake. Remedy Meds requires completing a full intake questionnaire—including contact information and health history—before displaying any pricing. For readers who prefer to compare rates without submitting personal information, PlexusDx offers immediate visibility. For readers comfortable with intake-gated pricing, Remedy's quiz may help tailor the recommendation before revealing cost.

Product range and format options

PlexusDx offers five compounded GLP-1 formats: microdose injection, standard semaglutide injection, standard tirzepatide injection, oral semaglutide capsules, and oral tirzepatide capsules. Remedy Meds' verified offerings are compounded semaglutide and tirzepatide injections, plus a microdose plan; oral formats are not documented. Readers seeking oral capsule options will find them only at PlexusDx in this comparison.

Ongoing support and care bundle

Remedy Meds includes unlimited clinician visits, phone support, and a U.S.-based care team in every monthly price. The program also advertises a "Remedy Weight Loss Warranty" with a "guaranteed or it's free" clause (specific terms not captured). PlexusDx includes the initial provider consultation, prescription, and medication in the monthly rate but does not advertise unlimited follow-up visits or a results warranty. Readers who anticipate needing frequent check-ins or want a money-back structure may value Remedy's bundled support model.

Multi-month discount availability

PlexusDx offers lower per-month rates on prepaid 3-month and 6-month commitments (for example, semaglutide drops to $149/month on a 6-month plan). Remedy Meds advertises month-to-month billing with no long-term commitment; multi-month prepay discounts are not documented. Readers comfortable committing upfront can access deeper savings at PlexusDx; readers who prefer pure month-to-month flexibility without evaluating prepay trade-offs may prefer Remedy's billing model.

Same-price-at-every-dose vs dose-tiered pricing

PlexusDx charges the same monthly rate regardless of dose progression—a 0.25 mg weekly semaglutide dose costs the same as 2.4 mg. Remedy Meds' dose-pricing policy is not documented in the captured evidence. Readers who expect to titrate to higher maintenance doses may benefit from PlexusDx's flat-rate structure.

Choose Remedy Meds if…

• You want unlimited clinician visits and phone support included in the monthly price without add-on fees.
• A results warranty matters to your decision, and you are comfortable reviewing the specific "guaranteed or it's free" terms at checkout.
• You prefer completing an intake questionnaire and receiving a tailored program recommendation before seeing pricing.
• You value a U.S.-based care team as an explicit program feature.
• Standard injectable semaglutide or tirzepatide meets your needs, and you confirm the advertised monthly rate at checkout matches your budget (approximately $299 semaglutide, $399 tirzepatide per secondary evidence).

Choose PlexusDx if…

• You want to compare program prices upfront, without completing an intake form or submitting contact information first.
• Microdose GLP-1 fits your clinical situation, and $129/month represents a $60/month ($720/year) savings over Remedy's verified $189 microdose rate.
• You are considering standard semaglutide ($189/month) or tirzepatide ($289/month) and prefer transparent, published pricing that does not change by dose.
• Oral capsule formulations—semaglutide or tirzepatide—are part of your decision set.
• You prefer the option of prepaying for 3 or 6 months in exchange for lower per-month rates (for example, tirzepatide at $249/month on a 6-month plan vs $289 month-to-month).
• You want the same monthly price at every dose level, from initiation through maintenance.

Methodology and freshness

All Remedy Meds prices were captured or verified September 4, 2026, from intake completion (microdose $189) and secondary published sources (semaglutide ~$299, tirzepatide ~$399). Remedy's standard semaglutide and tirzepatide figures are flagged as mixed/secondary evidence; the microdose rate is the only figure verified through direct intake. PlexusDx pricing is current as of the publish date and is drawn from live product pages. The 12-month cost calculations are ours, multiplying stated monthly rates by 12 for like-for-like comparison. Prepaid per-month equivalents (PlexusDx 3-month and 6-month plans) are our calculation and require upfront payment. No promotional or first-month pricing was identified for either program. Readers should confirm Remedy Meds pricing at checkout given limited public transparency. We refreshed Trustpilot ratings for both programs on September 4, 2026.

Frequently Asked Questions

Does Remedy Meds publish pricing before I complete an intake?

No. Remedy Meds displays pricing only after you complete a full intake questionnaire, including contact information and health history. PlexusDx publishes all program prices upfront on product pages, so you can compare rates before starting an intake.

Which program costs less for microdose GLP-1?

PlexusDx microdose is $129/month; Remedy Meds microdose is $189/month (verified September 4, 2026). Over 12 months, PlexusDx costs $1,548 and Remedy costs $2,268—a $720 difference. Both figures are all-inclusive with no membership fees.

What is included in Remedy Meds' monthly price?

Remedy Meds includes medication, unlimited clinician visits, phone support, a U.S.-based care team, and shipping in every monthly rate. The program also advertises a "Remedy Weight Loss Warranty" with a money-back structure, though specific terms were not captured in our research.

Can I get tirzepatide in oral capsule form from Remedy Meds?

Not documented. Remedy's verified product offerings are compounded semaglutide and tirzepatide injections, plus a microdose injection plan. PlexusDx offers oral semaglutide capsules at $289/month and oral tirzepatide capsules at $349/month (month-to-month rates).

Does PlexusDx offer multi-month discounts?

Yes. PlexusDx offers lower per-month rates on prepaid 3-month and 6-month commitments. For example, semaglutide injection is $189/month month-to-month, $169/month on a 3-month plan (prepaid), or $149/month on a 6-month plan (prepaid). Remedy Meds advertises month-to-month billing; multi-month discounts are not documented.

Sources

• Remedy Meds pricing and program details captured from intake completion and secondary published reviews, September 4, 2026
• PlexusDx microdose pricing verified July 20, 2026; standard injectable and oral pricing current as of publish date
• Remedy Meds Trustpilot rating (4.7 stars) displayed during intake, captured September 4, 2026
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four stars or higher) verified September 9, 2026
• 12-month cost calculations are our own, derived from stated monthly rates

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.